XRCC1 and urinary bladder carcinoma: Previous studies investigating the associations between XRCC1 Polymorphisms and bladder cancer risk have provided inconsistent results, and most of those studies involved no more than a few hundred bladder cancer cases, which is too few to assess any genetic effects reliably.